Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.660
-0.030 (-1.78%)
At close: Nov 6, 2025, 4:00 PM EST
1.670
+0.010 (0.60%)
After-hours: Nov 6, 2025, 7:56 PM EST
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $146.45 million as of November 6, 2025. Its market cap has increased by 673.62% in one year.
Market Cap
146.45M
Enterprise Value
107.50M
1-Year Change
673.62%
Ranking
Category
Stock Price
$1.66
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $146.45M, a decrease of -42.89%. That is a compound annual growth rate of -12.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 149.10M | 411.70% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
| Oct 8, 2021 | 256.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 828.96B |
| Johnson & Johnson | 448.13B |
| AbbVie | 383.12B |
| UnitedHealth Group | 296.88B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 216.56B |
| Thermo Fisher Scientific | 213.27B |